Team – Biophage, Inc.

Leadership Team

Meet the scientists, veterinarians, and regulators guiding Biophage’s phage therapies from lab to pasture.

Core Team

An advanced veterinary treatment bay designed for large animals, with a clean, rubberized floor and a sturdy, empty equine examination stall framed by brushed stainless-steel rails. On a nearby mobile cart, a sealed, clearly labeled “Bacteriophage Therapy – Equine Respiratory” infusion bag rests beside sterile tubing and a compact, digital infusion pump. Cool white ceiling lights provide bright, shadow-minimized illumination, reflecting gently off metal surfaces and emphasizing sterility and safety. The photographic composition is at eye level, using leading lines from the stall rails to draw attention toward the treatment cart. The mood is professional, reassuring, and highly clinical, illustrating how Biophage, Inc.’s therapies integrate seamlessly into modern veterinary practice without showing any animals or people.

Aarav Sharma

CEO

A dramatic, ultra-detailed close-up of a stylized bacteriophage rendered as if photographed through a high-end electron microscope, with a geometric icosahedral head and slender tail fibers attaching to a textured, rod-shaped bacterium. The color palette is deep cyan and soft teal, with selective bright accents to differentiate viral and bacterial structures. A faint grid and data overlays hover in the blurred background, hinting at genomic analysis. Subtle studio-style lighting from one side creates crisp highlights along the viral capsid edges and gentle shadows on the bacterial surface. Shot in macro, with a shallow depth of field and photographic realism, the image feels precise, modern, and scientific, ideal for explaining phage mechanisms to investors.

Mateo García

CTO

A sleek stainless-steel bioreactor vessel labeled “Biophage, Inc.” standing on a spotless white lab bench, surrounded by neatly arranged glass flasks filled with pale amber bacterial cultures, each marked with livestock pathogen strain codes. In the background, refrigerated incubators and a large digital screen display a crisp, blue-toned schematic of a bacteriophage attacking bacteria. Cool, even overhead laboratory lighting reflects subtly off metal and glass, creating a professional, clinical atmosphere. Captured at eye level with photographic realism and moderate depth of field so the bioreactor and screen are in sharp focus while the distant lab equipment softens, the composition emphasizes innovation and precision in veterinary bacteriophage therapy.

Zuri Ndlovu

Developer

A meticulously organized regulatory strategy workspace, featuring a large, matte-white desk with a slim laptop displaying an EPA and FDA submission dashboard filled with clean charts and timelines. Beside it lie neatly stacked briefing binders labeled “EPA Biopesticide Dossier” and “FDA Veterinary Biologic,” along with color-coded sticky-note tabs and a polished steel pen. In the background, a glass wall reveals frosted icons of bacteriophages and livestock silhouettes. Soft, diffused daylight from a nearby window mixes with cool overhead office lighting, eliminating harsh shadows and creating a calm, focused atmosphere. Shot from a slightly elevated angle in photographic realism with sharp focus throughout, the composition communicates investor-ready regulatory planning and disciplined biotech operations.

Leila Haddad

Designer

A clean, modern infographic-style laboratory scene where a transparent acrylic petri dish containing a neat bacterial lawn shows precise, circular zones of clearing labeled as “phage activity.” The dish rests on a smooth, light-gray benchtop near a tablet displaying a blue-and-green dashboard of efficacy metrics for different livestock pathogens. Backdrop shelves hold color-coded reagent bottles and a small phage storage freezer with a glowing digital temperature readout. Soft, even overhead lab lighting and a subtle backlight behind frosted glass panels create a bright, analytical atmosphere. Photographic realism with a medium close-up, shallow depth of field keeps the petri dish in sharp focus while the background blurs slightly, emphasizing measurable results and data-driven development in bacteriophage therapeutics.

Hiroshi Tanaka

Marketing

Amara Okafor

Social

About

Advisors and Strategic Collaborators

Meet advisors

Our advisory board brings together large-animal clinicians, microbiologists, ranch operators, and former FDA and EPA officials. They help shape trial design, biosecurity strategy, and regulatory submissions so our phage therapies fit seamlessly into real-world herd management. From mitigating antimicrobial resistance to navigating federal approvals, these collaborators ensure Biophage solutions are both scientifically rigorous and commercially scalable.